Up-front carfilzomib, lenalidomide, and dexamethasone with transplant for patients with multiple myeloma: the IFM KRd final results
Author:
Murielle Roussel,Valerie Lauwers-Cances,Soraya Wuilleme,Karim Belhadj,Salomon Manier,Laurent Garderet,Martine Escoffre-Barbe,Clara Mariette,Lotfi Benboubker,Denis Caillot,Cécile Sonntag,Cyrille Touzeau,Jehan Dupuis,Philippe Moreau,Xavier Leleu et al.
Copyright © 2021 American Society of Hematology.